New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 23, 2014
10:01 EDTCTCM, TTM, QSII, TV, BRO, RUSHA, PHG, LLY, AEGN, RXN, PNROn The Fly: Analyst Downgrade Summary
Aegion (AEGN) downgraded to Neutral from Buy at Sidoti... Brown & Brown (BRO) downgraded to Neutral from Buy at Compass Point... CTC Media (CTCM) downgraded to Underperform from Neutral at Credit Suisse... Eli Lilly (LLY) downgraded to Neutral from Buy at MKM Partners... Grupo Televisa (TV) downgraded to Underperform from Neutral at BofA/Merrill... Pentair (PNR) downgraded to Neutral from Outperform at Wedbush... Philips (PHG) downgraded to Sector Perform from Outperform at RBC Capital... Quality Systems (QSII) downgraded to Underweight from Equal Weight at Morgan Stanley... Rexnord (RXN) downgraded at BofA/Merrill... Rush Enterprises (RUSHA) downgraded to Equal Weight from Overweight at Stephens... Tata Motors (TTM) downgraded to Neutral from Outperform at Credit Suisse.
News For AEGN;BRO;CTCM;LLY;TV;PNR;PHG;QSII;RXN;RUSHA;TTM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
January 26, 2015
17:29 EDTBROBrown & Brown reports Q4 adjusted EPS 36c, consensus 15c
Subscribe for More Information
15:30 EDTBRONotable companies reporting after market close
Subscribe for More Information
08:08 EDTRXNMetso Oyj acquires certain IP rights from Rexnord
Subscribe for More Information
January 23, 2015
12:18 EDTQSIIQuality Systems management to meet with Topeka
Subscribe for More Information
January 22, 2015
12:20 EDTQSIIQuality Systems upgraded earlier to Hold from Sell at Evercore ISI
Subscribe for More Information
10:03 EDTPNROn the Fly: Analyst Initiation Summary
Subscribe for More Information
10:03 EDTPNROn the Fly: Analyst Downgrade Summary
Subscribe for More Information
06:33 EDTPNRPentair downgraded to Neutral from Outperform at RW Baird
05:34 EDTQSIIQuality Systems reports Q3 non-GAAP EPS 16c, consensus 14c
Subscribe for More Information
January 21, 2015
16:12 EDTPNRPentair initiated with a Neutral at UBS
Subscribe for More Information
10:16 EDTLLYLeerink biopharma analysts hold an analyst/industry conference call
Analyst Fernandez, along with Dr. Paul Gurbel and Dr. Richard Becker, discuss AstraZeneca's PEGASUS trial and the current use of Brilinta and dual antiplatelet therapy for prevention of CV disease and implications of the recently completed DAPT trial on an Analyst/Industry conference call to be held on January 21 at 1:30 pm.
January 20, 2015
06:05 EDTRXNRexnord downgraded to Sell from Neutral at Goldman
Subscribe for More Information
January 19, 2015
16:21 EDTCTCMCTC Media downgraded to Sell from Neutral at Goldman
Goldman Sachs downgraded CTC Media to Sell saying the Russian advertising market outlook remains "very uncertain" given the weakness in the ruble. Goldman expects Russia's TV ad market to drop 20% year-over-year in FY15. The firm cut its price target for CTC shares to $3 from $6.10. Shares of the Russian television operator closed Friday up 6c to $4.75.
16:17 EDTCTCMYandex downgraded to Sell from Neutral at Goldman
Subscribe for More Information
January 15, 2015
11:20 EDTLLYGoldman cuts J&J to sell citing competitive pressures
Subscribe for More Information
10:00 EDTLLYOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:07 EDTLLYEli Lilly upgraded at Goldman
As previously reported, Goldman upgraded Eli Lilly to Neutral from Sell. The firm upgraded shares based on new product launches and pipeline assets, and cost reductions. Price target is $70.
06:44 EDTLLYEli Lilly upgraded to Neutral from Sell at Goldman
Subscribe for More Information
January 14, 2015
10:00 EDTPHGOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:37 EDTPHGPhilips upgraded to Neutral from Underperform at Exane BNP Paribas
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use